Wall St Price Targets

TXG Price Forecast
Based on 15 analysts

+20% Upside
from $59.28 today

10X Genomics Inc (TXG)’s 12-month stock price forecast through November 2027 has a consensus target of $71.4, implying 20% upside. The forecast is based on price targets from 15 Wall Street analysts.

TXG Analyst Rating
Based on 17 analysts

avg. 3.65 of 5
Strong buy
5 29%
Buy
1 6%
Hold
11 65%
Sell
0 0%
Strong sell
0 0%

Analysts rate TXG Buy, with 6 of 17 recommending Buy or Strong buy.

10X Genomics Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TXG's stock price target?
Price Target
71.4 USD

According to Wall Street analysts, the average 1-year price target for TXG is 71.4 USD with a low forecast of 40.4 USD and a high forecast of 115.5 USD.

What is the Revenue forecast for 10X Genomics Inc?
Projected CAGR
10%

Over the last 7 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 8 years is 10%.

What is the Gross Profit forecast for 10X Genomics Inc?
Projected CAGR
10%

Over the last 7 years, the compound annual growth rate for Gross Profit has been 21%. The projected CAGR for the next 8 years is 10%.

Back to Top